Literature DB >> 10609165

[Anti-ischemic effect of verapamil within the scope of interventional recanalization].

O Oldenburg1, D Baumgart, J Schaar, H Eggebrecht, G Caspari, M Haude, R Erbel.   

Abstract

We report on a 46-year-old male with unstable angina pectoris due to a total proximal occlusion of the left circumflex artery. At the side of a plaque rupture there was a thrombotic occlusion. With PTCA recanalization was possible, but a dissection occurred, therefore coronary stents were implanted. Besides an optimal morphological result and recurrent applications of nitroglycerin, the baseline blood flow velocity declined from initial 16 cm/s to 11 cm/s after PTCA down to 8.4 cm/s after stent implantation. Because peak flow velocity remained almost unchanged, the low baseline velocity ("slow flow phenomenon") did not lead to an impaired coronary flow velocity reserve (CFVR). Only after application of 1 mg verapamil, a sustained flow velocity on a higher baseline level was reached (17 cm/s), at the same time typical signs of ischemia in the ECG (ST-segment depressions) improved. Additionally, in the non-treated LAD there was an increase in coronary blood flow velocity from 10 cm/s up to 25 cm/s. The reduction in coronary blood flow velocity with increasing manipulations might be due to an impairment of the coronary microcirculations with increasing alpha-adrenergic vasoconstriction, a distribution of vasoactive agents and peripheral microembolizations. Only after administration of verapamil, a calcium channel blocker with non-specific anti-adrenergic effects, the slow flow was removed and ECG signs of ischemia improved. The blood flow velocity in the non-treated LAD was low at baseline and improved after verapamil. This phenomenon leads to the conclusion that mechanisms with vasoconstrictive effect are present in the whole coronary system, but these mechanisms are less pronounced in non-treated vessels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609165     DOI: 10.1007/bf03044230

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  14 in total

1.  Appreciating alpha-adrenergic receptors and their role in ischemic left ventricular dysfunction.

Authors:  M J Kern
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

2.  Unstable angina. A classification.

Authors:  E Braunwald
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

3.  Role of intravascular ultrasound imaging in identifying vulnerable plaques.

Authors:  J Ge; D Baumgart; M Haude; G Görge; C von Birgelen; S Sack; R Erbel
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

4.  Enhanced coronary vasoconstriction after PTCA in patients with acute ischemia.

Authors:  L Mandinov; P Kaufmann; F Eberli; O M Hess
Journal:  Basic Res Cardiol       Date:  1998       Impact factor: 17.165

5.  Intracoronary gallopamil during percutaneous transluminal coronary angioplasty.

Authors:  B Rauch; G Richardt; R Barth; R Zimmermann; H Tillmanns; A Schömig; W Kübler; F J Neumann
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

6.  Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents.

Authors:  L Gregorini; J Fajadet; G Robert; B Cassagneau; M Bernis; J Marco
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

7.  Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction.

Authors:  L Gregorini; J Marco; M Kozàkovà; C Palombo; G B Anguissola; I Marco; M Bernies; B Cassagneau; A Distante; I M Bossi; J Fajadet; G Heusch
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

Review 8.  Calcium antagonists for acute ischemic heart disease.

Authors:  M D Winniford; J T Willerson; L D Hillis
Journal:  Am J Cardiol       Date:  1985-01-25       Impact factor: 2.778

9.  Impaired coronary vasodilator reserve in the immediate postcoronary angioplasty period: analysis of coronary artery flow velocity indexes and regional cardiac venous efflux.

Authors:  M J Kern; U Deligonul; M Vandormael; A Labovitz; C V Gudipati; G Gabliani; J Bodet; Y Shah; H L Kennedy
Journal:  J Am Coll Cardiol       Date:  1989-03-15       Impact factor: 24.094

10.  Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses.

Authors:  G Heusch; A Deussen
Journal:  J Cardiovasc Pharmacol       Date:  1984 May-Jun       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.